Funding and Award Opportunities for Cancer Research
|Award Name:||Max Ritvo, Alan Slifka and Desiree Dato Fund for Fusion-Oncoprotein Cancers and Metastasis|
|Funding Sponsor:||Samuel Waxman Cancer Research Foundation, Israel Cancer Research Fund, The Alan B. Slifka Foundation|
|Funding Sponsor Link:||https://www.waxmancancer.org/|
The total amount of the grant is $250,000: $125,000 directed to the USA and $125,000 to Israel.
Internal LOI Deadline: Wednesday, March 25, 2020
Agency LOI Deadline: Wednesday, April 1, 2020
This is a grant to support collaborative science conducted by co-investigators in the USA and Israel. The awards should address one of the two following topics: 1. Cancers driven by fusion oncoproteins with Ewing sarcoma as the prototype; and 2. Role of either epigenetics or tumor microenvironment in the development of metastatic cancer.
|Information And Eligibilty Criteria:||
USA faculty with established collaboration with Israeli faculty.
If you are interested in applying for this funding opportunity, please upload the following at https://administration.uccrc.org/ for institutional review:
- PI name from USA; PI name and institution from Israel
- Background of both researchers
- Key preliminary data, premise, and rigor of underlying research
- Hypothesis and Specific Aims
- Evidence for collaboration synergism
- Novelty and potential translational impact
For more information on this funding opportunity click HERE.
|Target Awardee:||--- - All Faculty|